[Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D015415:Biomarkers; D003228:Conjunctiva / Q000737:chemistry / Q000187:drug effects*; D003231:Conjunctivitis / Q000139:chemically induced / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects; D005260:Female; D005901:Glaucoma / Q000188:drug therapy / Q000378:metabolism; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D008297:Male; D008875:Middle Aged; D055271:Mucin 5AC; D018396:Mucin-1 / Q000032:analysis; D009077:Mucins / Q000032:analysis; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D013999:Timolol / Q000008:administration & dosage*
D000319:Adrenergic beta-Antagonists; D001548:Benzalkonium Compounds; D015415:Biomarkers; D006684:HLA-DR Antigens; C524678:MUC5AC protein, human; D055271:Mucin 5AC; D018396:Mucin-1; D009077:Mucins; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical; D018799:Intercellular Adhesion Molecule-1; D013999:Timolol
Retentissement conjonctival des conservateurs: étude comparative de collyres bêta-bloquants conservés et non conservés chez des patients glaucomateux.